A combined analysis of blood tests to measure three biomarkers linked to higher risk of cardiovascular disease—lipoprotein a (Lp(a)), remnant cholesterol and high-sensitivity C-reactive protein (hsCRP ...
A team of scientists has developed a highly accurate blood test for Chronic Fatigue Syndrome. The test reads tiny DNA patterns that reveal the biological signature of the illness. For millions who’ve ...
FITBOOK magazine on MSN
This Blood Value Should Be Checked at Least Once in Your Lifetime
Heart attack despite a healthy diet? Stroke without high blood pressure? The reason might lie in the blood–and few people know about it. Lipoprotein(a) is a value that is genetically determined and ...
A Bay Area biotech company is behind a potentially groundbreaking blood test that promises to be a game-changer in cancer ...
Lara Vukelich is a freelance writer in San Diego, California. She writes creative content and SEO-driven copy that can be found everywhere from Huffington Post and Quiet Revolution to Expedia, ...
A pioneering blood test designed to screen for more than 50 types of cancer, currently being evaluated by the NHS, has correctly identified the disease in nearly two-thirds of cases it flagged. The ...
FDA cleared the Elecsys pTau181 test as the first blood-based biomarker to aid in the initial assessment of Alzheimer's disease and other causes of cognitive decline that can be used in the primary ...
The U.S. Food and Drug Administration has approved a second blood test to improve the detection of Alzheimer’s disease. The “Elecsys pTau181 test” measures pTau181 protein levels in human plasma which ...
Roche, which currently has investigational Alzheimer’s disease drug trontinemab in phase 3 trials, has secured FDA clearance of its blood-based biomarker test for the condition. The minimally invasive ...
Roche's Elecsys pTau181 test is the second blood-based biomarker test to receive FDA clearance for Alzheimer’s disease this year. - Sarah Silbiger/Getty Images The US Food and Drug Administration has ...
Oct 13 (Reuters) - Roche Diagnostics (ROG.S), opens new tab said on Monday the U.S. Food and Drug Administration cleared its and partner Eli Lilly's (LLY.N), opens new tab blood test as an aid in the ...
The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other causes of cognitive decline, providing a broader understanding of when the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback